Gilenya in Amyotrophic Lateral Sclerosis (ALS)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to determine whether Gilenya, also known as fingolimod, is safe and tolerable in patients with Amyotrophic Lateral Sclerosis (ALS).
Epistemonikos ID: 30a59c5a5db54ca1a1ce14eb7c117bf7a2454d77
First added on: May 11, 2024